Prophylactic Interventions in Neonatology: How Do They Fare in Real Life?

American Journal of Perinatology

Volumn 32, Issue 12, 2015, Pages 1098-1104

  Rolnitsky, Asaph ^a   Lee, Shoo K ^a   Piedbouf, Bruno ^b   Harrison, Adele ^c   Shah, Prakesh S ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

indomethacin; infant; outcome; phototherapy; premature; prophylaxis; steroids

Indexed keywords

BILIRUBIN; CORTICOSTEROID; INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT; STEROID;

APGAR SCORE; BILIRUBIN BLOOD LEVEL; BIRTH WEIGHT; CESAREAN SECTION; CONFERENCE PAPER; DUCTUS ARTERIOSUS OBLITERATION; FEMALE; GESTATIONAL AGE; HOSPITAL ADMISSION; HOSPITAL INFECTION; HUMAN; INFANT; LUNG DYSPLASIA; MAJOR CLINICAL STUDY; MALE; MATERNAL DIABETES MELLITUS; MATERNAL HYPERTENSION; NECROTIZING ENTEROCOLITIS; NEONATOLOGY; NEUROLOGIC DISEASE; NEWBORN INTENSIVE CARE; NEWBORN MORBIDITY; NEWBORN MORTALITY; PATENT DUCTUS ARTERIOSUS; PHOTOTHERAPY; PREMATURITY; PRENATAL CARE; PRIORITY JOURNAL; PROPHYLAXIS; RETINOPATHY; RETROSPECTIVE STUDY; SMALL FOR DATE INFANT; STEROID THERAPY; TREATMENT OUTCOME; BRONCHOPULMONARY DYSPLASIA; CANADA; CLINICAL TRIAL; CROSS INFECTION; DUCTUS ARTERIOSUS, PATENT; INFANT MORTALITY; LIGATION; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; NEWBORN; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC); STATISTICAL MODEL;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BRONCHOPULMONARY DYSPLASIA; CANADA; CROSS INFECTION; DUCTUS ARTERIOSUS, PATENT; FEMALE; GESTATIONAL AGE; HUMANS; INDOMETHACIN; INFANT; INFANT MORTALITY; INFANT, EXTREMELY PREMATURE; INFANT, NEWBORN; INTENSIVE CARE UNITS, NEONATAL; LIGATION; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; NEONATOLOGY; PHOTOTHERAPY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RETROSPECTIVE STUDIES; STEROIDS;

EID: 84943664208     PISSN: 07351631     EISSN: 10988785     Source Type: Journal    
DOI: 10.1055/s-0035-1556882     Document Type: Conference Paper

References (29)

1. Steer P. The epidemiology of preterm labour. BJOG: 2005; 112 01 1 3
2. Stoll B. J., Hansen N. I., Bell E. F., et al. Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network. Pediatrics: 2010; 126 3 443 456
3. Roberts D., Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev: 2006; 3 3 CD004454
4. Doyle L. W., Crowther C. A., Middleton P., Marret S., Rouse D. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. Cochrane Database Syst Rev: 2009; 1 1 CD004661
5. Cools F., Henderson-Smart D. J., Offringa M., Askie L. M. Elective high frequency oscillatory ventilation versus conventional ventilation for acute pulmonary dysfunction in preterm infants. Cochrane Database Syst Rev: 2009; 3 3 CD000104
6. Darlow B. A., Graham P. J. Vitamin A supplementation to prevent mortality and short- and long-term morbidity in very low birthweight infants. Cochrane Database Syst Rev: 2011; 10 10 CD000501
7. Rojas-Reyes M. X., Morley C. J., Soll R. Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev: 2012; 3 CD000510
8. Fowlie P. W., Davis P. G., McGuire W. Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants. Cochrane Database Syst Rev: 2010; 7 7 CD000174
9. Alfaleh K., Anabrees J., Bassler D., Al-Kharfi T. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev: 2011; 3 3 CD005496
10. Shah P., Shah V. Arginine supplementation for prevention of necrotising enterocolitis in preterm infants. Cochrane Database Syst Rev: 2007; 3 3 CD004339
11. Okwundu C. I., Okoromah C. AN, Shah P. S. Prophylactic phototherapy for preventing jaundice in preterm or low birth weight infants. Cochrane Database Syst Rev: 2012; 1 CD007966
12. Clerihew L., Austin N., McGuire W. Prophylactic systemic antifungal agents to prevent mortality and morbidity in very low birth weight infants. Cochrane Database Syst Rev: 2007; 4 4 CD003850
13. Ohlsson A., Lacy J. B. Intravenous immunoglobulin for preventing infection in preterm and/or low-birth-weight infants. Cochrane Database Syst Rev: 2004; 1 1 CD000361
14. Rich W. D., Auten K. J., Gantz M. G., et al. National Institute of Child Health and Human Development Neonatal Research Network. Antenatal consent in the SUPPORT trial: challenges, costs, and representative enrollment. Pediatrics: 2010; 126 1 e215 e221
15. Rich W., Finer N. N., Gantz M. G., et al. SUPPORT and Generic Database Subcommittees of the Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Enrollment of extremely low birth weight infants in a clinical research study may not be representative. Pediatrics: 2012; 129 3 480 484
16. Canadian Neonatal Network Abstractor's Manual v2.00. 2012; Available at: http://www.canadianneonatalnetwork.org. Accessed August 20, 2014
17. Papile L. A., Burstein J., Burstein R., Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr: 1978; 92 4 529 534
18. International Committee for the Classification of Retinopathy of Prematurity The International Classification of Retinopathy of Prematurity revisited. Arch Ophthalmol: 2005; 123 7 991 999
19. Bell M. J., Ternberg J. L., Feigin R. D., et al. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Ann Surg: 1978; 187 1 1 7
20. Jobe A. H., Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med: 2001; 163 7 1723 1729
21. Morris B. H., Oh W., Tyson J. E., et al. NICHD Neonatal Research Network. Aggressive vs. conservative phototherapy for infants with extremely low birth weight. N Engl J Med: 2008; 359 18 1885 1896
22. Richardson D. K., Corcoran J. D., Escobar G. J., Lee S. K. SNAP-II and SNAPPE-II: Simplified newborn illness severity and mortality risk scores. J Pediatr: 2001; 138 1 92 100
23. Janvier A., Lantos J., Barrington K. The politics of probiotics: probiotics, necrotizing enterocolitis and the ethics of neonatal research. Acta Paediatr: 2013; 102 2 116 118
24. Mondal T., Chaudhuri D., Li B., Shivananda S., Dutta S. Prophylactic indomethacin worsens short-term respiratory outcomes in extremely low-birth-weight infants. Am J Perinatol: 2014; 31 1 61 67
25. Schmidt B., Roberts R. S., Fanaroff A., et al. TIPP Investigators. Indomethacin prophylaxis, patent ductus arteriosus, and the risk of bronchopulmonary dysplasia: further analyses from the Trial of Indomethacin Prophylaxis in Preterms (TIPP). J Pediatr: 2006; 148 6 730 734
26. Koch J., Hensley G., Roy L., Brown S., Ramaciotti C., Rosenfeld C. R. Prevalence of spontaneous closure of the ductus arteriosus in neonates at a birth weight of 1000 grams or less. Pediatrics: 2006; 117 4 1113 1121
27. Liu G-S, Wu H., Wu B-Q, Huang R-Z, Zhao L-H, Wen Y. Effect of phototherapy on blood endothelin and nitric oxide levels: clinical significance in preterm infants. World J Pediatr: 2008; 4 1 31 35
28. Bertini G., Perugi S., Elia S., Pratesi S., Dani C., Rubaltelli F. F. Transepidermal water loss and cerebral hemodynamics in preterm infants: conventional versus LED phototherapy. Eur J Pediatr: 2008; 167 1 37 42
29. Benders M. J., van Bel F., van de Bor M. Haemodynamic consequences of phototherapy in term infants. Eur J Pediatr: 1999; 158 4 323 328